Enterprise League logo

CRISPR-cas12 Therapeutics | HuidaGene Therapeutics

Product description

HuidaGene is developing CRISPR-cas12 therapeutics for a range of diseases, utilizing our proprietary technology platform to deliver precise gene editing solutions.

Price: N/A